148 active trials 91 recruiting 9 Phase 3 43 disease areas 12 changes in 30 days
5 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 3 with minor changes only.
Primary completion pushed from Dec 2025 to Jun 2027
Also in this update: Enrollment closed, study ongoing; Final enrollment: 340 participants (planned 300)
University Medical Center GroningenPhase 2 NCT05641428 Registry history of NCT05641428 on ClinicalTrials.gov (opens the registry)
Updated
Primary completion date changed from estimate of Jan 1, 2026 to Jul 1, 2026
Also in this update: Trial completed; Final enrollment: 703 participants (planned 1300)
University Medical Center GroningenNot applicable NCT05773768 Registry history of NCT05773768 on ClinicalTrials.gov (opens the registry)
Updated
Trial status changed: Enrolling by Invitation → Active, Not Recruiting
University Medical Center GroningenPhase 3 NCT05374291 Registry history of NCT05374291 on ClinicalTrials.gov (opens the registry)
Updated
Trial sites expanded: 25 → 30 locations
And 2 more changes in the last 30 days
University Medical Center GroningenNot specified NCT07585890 Registry history of NCT07585890 on ClinicalTrials.gov (opens the registry)
Updated
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
University Medical Center GroningenNot applicable NCT06616129 Registry history of NCT06616129 on ClinicalTrials.gov (opens the registry)
Changed
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-08 | NCT07866547 Off-line Adaptive Proton Therapy | Not Yet Recruiting | |
| 2026-09-14 | NCT07819227 Optimizing Albuminuria Treatment in CKD With Finerenone and Semaglutide | Phase 2 | Completed |
| Phase 1 | 7 | |
| Phase 1/2 | 7 | |
| Phase 2 | 17 | |
| Phase 2/3 | 1 | |
| Phase 3 | 8 | |
| Phase 4 | 7 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT07645625 | Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer | Cervical Cancer | Recruiting | 2026-06-29 |
| NCT06256991 | Potassium Correction for RAAS Optimization in Chronic Kidney Disease | Chronic Kidney Diseases | Recruiting | 2025-12-19 |
| NCT05463913 | Lung Nodule Detection Using Ultra-long FOV PET/CT | Lung Cancer | Recruiting | 2025-03-07 |
| NCT05525338 | Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib… | Drug Monitoring | Recruiting | 2024-05-13 |
| NCT07527390 | CANagliflozin In DIALysis Patients | Dialysis | Not Yet Recruiting | 2026-05-06 |
| NCT04646187 | De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease | Inflammatory Bowel Diseases | Enrolling by Invitation | 2025-01-06 |
| NCT03797196 | RCT Comparing Immunosuppressive Regimens in Elderly Renal Transplant Recipients | Renal Transplant Recipients | Active, Not Recruiting | 2023-05-10 |
| Phase 3 | ||||
| NCT05373264 | HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their… | ADPKD | Recruiting | 2026-08-25 |
| NCT06511089 | Carotid Artery Stenting During Endovascular Treatment of Acute Stroke | Stroke, Acute | Recruiting | 2024-07-19 |
| NCT04642027 | PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy | Prostate Cancer | Recruiting | 2024-02-28 |
| NCT05374291 | The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and… | Kidney Disease, Chronic | Active, Not Recruiting | 2026-10-08 |
| NCT01558921 | Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The… | Rectal Cancer | Active, Not Recruiting | 2026-05-01 |
| NCT07181135 | FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not… | Chronic Kidney Disease | Enrolling by Invitation | 2026-04-14 |
| NCT04302454 | Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to… | Prostate Cancer | Active, Not Recruiting | 2025-04-04 |
| NCT03507010 | Ledderhose Disease: Radiotherapy or Not? | Ledderhose Disease | Active, Not Recruiting | 2024-02-28 |
| Phase 2/3 | ||||
| NCT07606014 | No Guts No Glory Probiotics | Patients Using Olanzapine, Quetiapine, Risperidone or Clozapine | Recruiting | 2026-05-26 |
| Phase 2 | ||||
| NCT07304817 | Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein… | CKD | Recruiting | 2026-05-29 |
| NCT06782724 | Psilocybin Therapy for Psychological Distress in Palliative Patients | COPD (Chronic Obstructive Pulmonary Disease) | Recruiting | 2026-05-08 |
| NCT05745857 | Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal… | Barrett's Esophagus Without Dysplasia | Recruiting | 2026-04-13 |
| NCT06534190 | CD8 PET Imaging in Metastatic Solid Tumours | Locally Advanced Solid Tumor | Recruiting | 2026-02-09 |
| NCT03938701 | Fluorescence Imaging of IBD and RA Using Adalimumab-800CW | IBD | Recruiting | 2025-08-19 |
| NCT07038304 | The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration… | Prostate Cancer (Adenocarcinoma) | Recruiting | 2025-06-26 |
| NCT05483400 | Open Label Phase 2 Basket Trial With Atezolizumab and Tiragolumab in Solid Tumors | Head and Neck Neoplasms | Recruiting | 2025-03-30 |
| NCT06518434 | A Pilot Study on the Effect of Cannabis Oil in Untreatable Liver Cancer Patients | Hepatocellular Carcinoma | Recruiting | 2024-07-24 |
| NCT05076942 | Groningen International Study on Sentinel Nodes in Vulvar Cancer-III | Vulvar Cancer | Recruiting | 2023-08-01 |
Head & Neck Cancer (9) · Heart Failure (9) · Lung Cancer (9) · Esophageal Cancer (8) · Breast Cancer (7) · COPD (7) · Non-Small Cell Lung Cancer (NSCLC) (6) · Chronic Kidney Disease (5) · Atrial Fibrillation (4) · Cervical Cancer (4)